SCHEMBL30616292

SCHEMBL30616292

[2H]c1c(C2CC2(C(N)=O)C(=O)Nc2ccc(F)cc2)ccc(Oc2ccnc3cc(OC)c(C(N)=O)cc23)c1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 19/20 0.59
▸ MERTK Q12866 9/20 0.58
▸ MET P08581 7/20 0.57
▸ KDR P35968 3/20 0.57
▸ RET P07949 2/20 0.51
▸ KIT P10721 2/20 0.51
▸ FLT3 P36888 2/20 0.51
▸ AURKA O14965 1/20 0.51
▸ RIPK2 O43353 1/20 0.51
▸ ABCB11 O95342 1/20 0.51
▸ ABL1 P00519 1/20 0.51
▸ EGFR P00533 1/20 0.51
▸ ERBB2 P04626 1/20 0.51
▸ NTRK1 P04629 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ PGR P06401 1/20 0.51
▸ LYN P07948 1/20 0.51
▸ CHRM2 P08172 1/20 0.51
▸ HCK P08631 1/20 0.51
▸ ADRA2A P08913 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30616277 0.91 AXL (0.51) AXLMERTKMETKDRRET
SCHEMBL29995716 0.89 AXL (0.72) AXLMERTKMETKDRRET
SCHEMBL31570685 0.87 MET (0.67) AXLMERTKMETKDRRET
SCHEMBL31330325 0.85 AXL (0.61) AXLMERTKMETKDRRET
SCHEMBL12807168 0.83 MET (0.70) AXLMERTKMETKDRRET
SCHEMBL1742894 0.83 MET (0.70) AXLMERTKMETKDRRET
SCHEMBL29972991 0.83 MET (0.70) AXLMERTKMETKDRRET
SCHEMBL28637610 0.83 AXL (0.74) AXLMERTKMETKDRRET
SCHEMBL29995530 0.81 AXL (0.65) AXLMERTKMETKDRRET
SCHEMBL21201052 0.81 AXL (0.86) AXLMERTKMETKDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117402114-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-01-16 — — CN disclosed
CN-111757735-B Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2023-09-22 — — CN disclosed
Send feedback